140
Views
18
CrossRef citations to date
0
Altmetric
Review Article

Derivation of inhalation toxicity reference values for propylene oxide using mode of action analysis: Example of a threshold carcinogen

, , , , , , , , , , , & show all
Pages 462-486 | Received 05 Jun 2008, Accepted 18 Feb 2009, Published online: 27 Mar 2009

References

  • Albertini, R.J., and Sweeney, L.M. (2007). Propylene oxide: Genotoxicity profile of a rodent nasal carcinogen. Crit. Rev. Toxicol. 37:489–520.
  • Boobis, A.R., Cohen, S.M., Dellarco, V., McGregor, D., Meek, M.E., Vickers, C., Willcocks, D., and Farland, W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 36:781–792.
  • Boogaard, P.J. (2002). Use of haemoglobin adducts in exposure monitoring and risk assessment. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 778:309–322.
  • Boogaard, P.J., Rocchi, P.S., and van Sittert, N. J. (1999). Biomonitoring of exposure to ethylene oxide and propylene oxide by determination of hemoglobin adducts: Correlations between airborne exposure and adduct levels. Int. Arch. Occup. Environ. Health 72:142–150.
  • Conolly, R.B., Kimbell, J.S., Janszen, D., Schlosser, P.M., Kalisak, D., Preston, J., and Miller, F.J. (2003). Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat. Toxicol. Sci. 75:432–447.
  • Conolly, R.B., Kimbell, J.S., Janszen, D., Schlosser, P.M., Kalisak, D., Preston,J., and Miller, F.J. (2004). Human respiratory tract cancer risks of inhaled formaldehyde: Dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human data set. Toxicol. Sci. 82:279–296.
  • Crump, K.S., Subramaniam, R.P., and VanLandingham, C.B. (2005). A numerical solution to the nonhomogeneous two-stage MVK model of cancer. Risk Anal. 25:921–926.
  • Csanády, G.A., and Filser, J.G. (2007). A physiological toxicokinetic model for inhaled propylene oxide in rat and human with special emphasis on the nose. Toxicol. Sci. 95:37–62.
  • Czene, K., Osterman-Golkar, S., Yun, X., Li, G., Zhao, F., Perez, H.L., Li, M., Natarajan, A.T., and Segerbäck, D. (2002). Analysis of DNA and hemoglobin adducts and sister chromatid exchanges in a human population occupationally exposed to propylene oxide: A pilot study. Cancer Epidemiol. Biomarkers Prev. 11:315–318.
  • Dunkelberg, H. (1979). On the oncogenic activity of ethylene oxide and propylene oxide in mice. Br. J Cancer 39:588–589.
  • Dunkelberg, H. (1981). Kanzerogene Aktivitat von Ethylenoxid und seinen Reaktionsprodukten 2-Chlorethanol, 2-Bromethanol, Ethylenglykol und Diethylenglykol. I. Kanzerogenitat von Ethylenoxid im Vergleich zu 1,2-Propylenoxid bei subkutaner Applikation an Mausen. Zentralbl. Bakteriol. Mikrobiol. Hyg. [B] 174:383–404.
  • Dunkelberg, H. (1982). Carcinogenicity of ethylene oxide and 1,2-propylene oxide upon intragastric administration to rats. Br. J Cancer 46:924–933.
  • Eldridge, S.R., Bogdanffy, M.S., Jokinen, M.P., and Andrews, L.S. (1995). Effects of propylene oxide on nasal epithelial cell proliferation in F344 rats. Fundam. Appl. Toxicol. 27:25–32.
  • Faller, T.H., Csanády, G.A., Kreuzer, P.E., Baur, C.M., and Filser, J.G. (2001). Kinetics of propylene oxide metabolism in microsomes and cytosol of different organs from mouse, rat, and humans. Toxicol. Appl. Pharmacol. 172:62–74.
  • Frederick, C.B., Lomax, L.G., Black, K.A., Finch, L., Scribner, H.E., Kimbell, J.S., Morgan, K.T., Subramaniam, R.P., and Morris, J.B. (2002). Use of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry comparisons of ester vapors. Toxicol. Appl. Pharmacol. 183:23–40.
  • Frederick, C.B., Potter, D.W., Chang-Mateu, M.I., and Andersen, M.E. (1992). A physiologically based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethyl acrylate and its implications for risk assessment. Toxicol. Appl. Pharmacol. 114:246–260.
  • Hackett, P.L., Brown, M.G., Buschbom, R.L., Clark, M.L., and Miller, R.A. (1982). Teratogenic study of ethylene and propylene oxide and n-butyl acetate. National Institute for Occupational Safety and Health, Cincinnati, OH, NTIS PB 83-258-38.
  • Hansen, B.G., Munn, S.J., Pakalin, S., Heidorn, C.J.A., Allanou, R., Pellegrini, G., Anfossi, V., Berthault, F., Naughton, A., Praderio, L., and Loonen, L. (Eds.). (2002). European Union Risk Assessment Report. Methyl oxirane (propylene oxide). CAS No. 75-56-9. EINIECS No. 200-879-2—EUR 29512/EN. Office for Official Publications of the European Communities, Luxembourg.
  • Hardin, B., Niemeier, R., Sikov, M., and Hackett, P. (1983). Reproductive toxicologic assessment of the epoxides ethylene oxide, propylene oxide, butylene oxide, and styrene oxide. Scand. J. Work. Environ. Health 9:94–102.
  • Harkema, J. (2006). Nasal histopathology of propylene oxide (PO)-exposed mice and rats. Michigan State University, East Lansing. May 31, 2006.
  • Harris, S.B., Schardein, J.L., Ulrich, C.E., and Ridlon, S.A. (1989). Inhalation developmental toxicity study of propylene oxide in Fischer 344 rats. Fundam. Appl. Toxicol. 13:232–331.
  • Haseman, J.K., and Hailey, J.R. (1997). An update of the National Toxicology Program database on nasal carcinogens. Mutat. Res. 380:3–11.
  • Hayes, W.C., Kirk, H.D. Gushow, T.S., and Young, J.T. (1988). Effect of inhaled propylene oxide on reproductive parameters in Fischer 344 rats. Fundam. Appl. Toxicol. 10:82–88.
  • Hill, A.B. (1965). The environment and disease: Association or causation? Proc. R. Soc. Med. 58:295–300.
  • Hotchkiss, J.A., Krieger, S.M., and Schisler, M.R. (2005). Effects of inhaled propylene oxide on nasal cell proliferation, biomarkers of exposure, and DNA lesions in male Fischer 344 rats and B6C3F1 mice. Phase 1. Inhalation exposure, in-life observations, necropsy, tissue sample isolation and shipping and determination of lung and liver non-protein sulfhydryl levels. Dow Chemical Company, Midland, MI. December 2, 2005.
  • Kenyon, E.M., Hughes, M.F., Adair, B.M., Highfill, J.H., Crecelius, E.A., Clewell, H.J., and Yager, J.W. (2008). Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water. Toxicol. Appl. Pharmacol. 232:448–455.
  • Khan, M.D.H., Klein, D., Mossbrugger, I., Oesterle, D., Csanády, Gy. A., Quintanilla-Martinez, L., and Filser, J.G. (2009). Is propylene oxide induced cell proliferation in rat nasal respiratory epithelium mediated by a severe depletion of water-soluble non-protein thiol? Toxicol. Lett., in press. 185:203–210.
  • Kimbell, J.S., Gross, E.A., Harkema, J.R., Godo, M.N., Richardson, R.B., Joyner, D.R., and Morgan, K.T. (1994). Spatial distribution and surface area of the major epithelial types in F344 rat anterior nasal passages. Am. J. Respir. Crit. Care Med. 149:A994.
  • Kimbell, J.S., Subramaniam, R.P., Gross, E.A., Schlosser, P.M., and Morgan, K.T. (2001). Dosimetry modeling of inhaled formaldehyde: Comparisons of local flux predictions in the rat, monkey, and human nasal passages. Toxicol. Sci. 64:100–110.
  • Kuper, C.F., Reuzel, P G., Feron, V.J., and Verschuuren, H. (1988). Chronic inhalation toxicity and carcinogenicity study of propylene oxide in Wistar rats. Food Chem. Toxicol. 26:159–167.
  • Lee, M.S., Faller, T.H., Kreuzer, P.E., Kessler, W., Csanády, G.A., Putz, C., Ríos-Blanco, M.N., Pottenger, L.H., Segerback, D., Osterman-Golkar, S., Swenberg, J.A., and Filser, J.G. (2005). Propylene oxide in blood and soluble nonprotein thiols in nasal mucosa and other tissues of male Fischer 344/N rats exposed to propylene oxide vapors—Relevance of glutathione depletion for propylene oxide-induced rat nasal tumors. Toxicol. Sci. 83:177–189.
  • Lynch, D.W., Lewis, T.R., Moorman, W.J., Burg, J.R., Groth, D.H., Khan, A., Ackerman, L.J., and Cockrell, B.Y. (1984a). Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F344 rats. Toxicol. Appl. Pharmacol. 76:69–84.
  • Lynch, D.W., Lewis, T. R., Moorman, W. J., Burg, J. R., Gulati, D. K., Kaur, P., and Sabharwal, P. S. (1984b). Sister-chromatid exchanges and chromosome aberrations in lymphocytes from monkeys exposed to ethylene oxide and propylene oxide by inhalation. Toxicol. Appl. Pharmacol. 76:85–95.
  • Meek, M.E., Bucher, J.R., Cohen, S.M., Dellarco, V., Hill, R.N., Lehman-McKeeman, L.D., Longfellow, D.G., Pastoor, T., Seed, J., and Patton, D.E. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol. 33:591–653.
  • Mercer, R.R., Russell, M.L., Roggli, V.L., and Crapo, J.D. (1994). Cell number and distribution in human and rat airways. Am. J. Respir. Cell Mol. Biol. 10:613–624.
  • Mlejnek, P., and Kolman, A. (1999). Effects of three epoxides—ethylene oxide, propylene oxide and epichlorohydrin—on cell cycle progression and cell death in human diploid fibroblasts. Chem. Biol. Interact. 117:219–39.
  • Moolgavkar, S. (1986). Carcinogenesis modeling: From molecular biology to epidemiology. Annu. Rev. Public Health 7:151–169.
  • Moolgavkar, S., and Knudson, A.G. Jr., (1981). Mutation and cancer: A model for human carcinogenesis. J. Natl. Cancer Inst. 66:1037–1052.
  • Moolgavkar, S.H., and Venzon, D.J. (1979). Two-event models for carcinogenesis: Incidence curves for childhood and adult tumors. Math. Biosci. 47:55–77.
  • Moolgavkar, S.H., Dewanji, A., and Venzon, D.J. (1988). A stochastic two-stage model for cancer risk assessment. I. The hazard function and the probability of tumor. Risk Anal. 8:383–392.
  • Morris, J.B., Banton, M.I., and Pottenger, L.H. (2004). Uptake of inspired propylene oxide in the upper respiratory tract of the F344 rat. Toxicol. Sci. 81:216–224.
  • Morris, J.B., and Pottenger, L.H. (2006). Propylene oxide uptake and nasal NPSH depletion in the upper respiratory tract of the mouse. Toxicol. Sci. 92:228–234.
  • National Toxicology Program. (1985). Toxicology and carcinogenesis studies of propylene oxide (CAS no. 75-56-9) in F344/N rats and B6C3F1 mice (Inhalation studies). Technical Report 267. Research Triangle Park, NC.
  • National Toxicology Program. (2005). Propylene oxide. CAS No. 75-56-9. Report on carcinogens, Eleventh edition. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. http://ntp.niehs.nih.gov/ntp/roc/eleventh/profiles/S155prop.pdf. Accessed November 14, 2008.
  • Ohnishi, A., Yamamato, T., Murai, Y., Hayashida, Y., Hori, H., and Tanaka, I. (1988). Propylene oxide causes central-peripheral distal axonopathy in rats. Arch. Environ. Health. 43:353–356.
  • Okuda, H., Takeuchi, T., Senoh, H., Arito, H., Nagano, K., Yamamoto, S., and Matsushima, T. (2006). Effects of inhalation exposure to propylene oxide on respiratory tract, reproduction and development in rats. J. Occup. Health 48:462–473.
  • Olsen, G.W., Lacy, S.E., Bodner, K.M., Chau, M., Arceneaux, T.G., Cartmill, J.B., Ramlow, J.M., and Boswell, J.M. (1997). Mortality from pancreatic and lymphopoietic cancer among workers in ethylene and propylene chlorohydrin production. Occup. Environ. Med. 54:592–598.
  • Osterman-Golkar, S., Perez, H.L., Csanády, G.A., Kessler, W., and Filser, J.G. (1999). Methods for biological monitoring of propylene oxide exposure in Fischer 344 rats. Toxicology 134:1–8.
  • Osterman-Golkar, S., Czene, K., Lee, M.S., Faller, T.H., Csanády, G.A., Kessler, W., Perez, H.L., Filser, J.G., and Segerbäck, D. (2003). Dosimetry by means of DNA and hemoglobin adducts in propylene oxide-exposed rats. Toxicol. Appl. Pharmacol. 191:245–254.
  • Ott, M.G., Teta, M.J., and Greenberg, H.L. (1989). Lymphatic and hematopoietic tissue cancer in a chemical manufacturing environment. Am. J. Ind. Med. 16:631–643.
  • Peden, D.B., Hohman, R., Brown, M.E., Mason, R.T., Berkebile, C., Fales, H.M., and Kaliner, M.A. (1990). Uric acid is a major antioxidant in human nasal airway secretions. Proc. Natl. Acad. Sci. USA 87:7638–7642.
  • Plna, K., Nilsson, R., Koskinen, M., and Segerbäck, D. (1999). 32P-postlabelling of propylene oxide 1- and N(6)-substituted adenine and 3-substituted cytosine/uracil: Formation and persistence in vitro and in vivo. Carcinogenesis. 20:2025–2032.
  • Pottenger, L.H, Hotchkiss, J.A., Krieger, S.M., Harkema, J.R., Banton, M.I., and Swenberg, J.A. (2008). Propylene oxide: Biomarkers of exposure, nasal cell proliferation, and cancer mode-of-action in rats and mice exposed via inhalation. Abstr. 519. Poster, 2008 SOT Annual Meeting, Seattle, WA.
  • Potter, D.W. and Tran, T.B. (1993). Apparent rates of glutathione turnover in rat tissues. Toxicol. Appl. Pharmacol. 120:186–92.
  • Preston, R.J., and Williams, G.M. (2005). DNA-reactive carcinogens: mode of action and human cancer hazard. Crit. Rev. Toxicol. 35:673–683.
  • Renne, R.A., Giddens, W.E., Boorman, G.A., Kovatch, R., Haseman, J.E., and Clarke, W.J. (1986). Nasal cavity neoplasia in F344/N rats and (C57BL/6 × C3H)F1 mice inhaling propylene oxide for up to two years. J. Natl. Cancer Inst. 77:573–582.
  • Reuzel, P.G., and Kuper, C.F. (1983). Chronic (28-month) inhalation toxicity/carcinogenicity study of 1,2-propylene oxide in rats; Final report. V82.215/280853. Netherlands, Division of Nutrition and Food Research,.
  • Ríos-Blanco, M.N., Faller, T.H., Nakamura, J., Kessler, W., Kreuzer, P.E., Ranasinghe, A., Filser, J.G., and Swenberg, J.A. (2000). Quantitation of DNA and hemoglobin adducts and apurinic/apyrimidinic sites in tissues of F344 rats exposed to propylene oxide by inhalation. Carcinogenesis 21:2011–2018.
  • Ríos-Blanco, M.N., Ranasinghe, A., Upton, P., Lee, M.S., Filser, J.G., and Swenberg, J.A. (2002). Exposure-dependent accumulation of N-(2-hydroxypropyl)valine in hemoglobin of F344 rats exposed to propylene oxide by the inhalation route. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 778:383–391.
  • Ríos-Blanco, M.N., Ranasinghe, A., Lee, M.S., Faller, T., Filser, J.G., and Swenberg, J.A. (2003a). Molecular dosimetry of N7-(2-hydroxypropyl)guanine in tissues of F344 rats after inhalation exposure to propylene oxide. Carcinogenesis 24:1233–1238.
  • Ríos-Blanco, M.N., Yamaguchi, S., Dhawan-Robl, M., Kessler, W., Schoonhoven, R., Filser, J.G., and Swenberg, J.A. (2003b). Effects of propylene oxide exposure on rat nasal respiratory cell proliferation. Toxicol. Sci. 75:279–288.
  • Segerbäck, D., Plna, K., Faller, T., Kreuzer, P. E., Hakansson, K., Filser, J.G., and Nilsson, R. (1998). Tissue distribution of DNA adducts in male Fischer rats exposed to 500 ppm of propylene oxide: Quantitative analysis of 7-(2-hydroxypropyl)guanine by 32P-postlabelling. Chem. Biol. Interact. 115:229–246.
  • Segerbäck D., Osterman-Golkar S., Molholt B., and Nilsson R. (1994). In vivo tissue dosimetry as a basis for cross-species extrapolation in cancer risk assessment of propylene oxide. Regul. Toxicol. Pharmacol. 20:1–14.
  • Sellakumar, A.R., Snyder, C.A., and Albert, R.E. (1987). Inhalation carcinogenesis of various alkylating agents. J. Natl.Cancer Inst. 79:285–289.
  • Setzer, J.V., Brightwell, W.S., Russo, J.M., Johnson, B.L., Lynch, D.W., Madden, G., Burg, J.R., and Sprinz, H. (1996). Neurophysiological and neuropathological evaluation of primates exposed to ethylene oxide and propylene oxide. Toxicol. Ind. Health 12:667–682.
  • Shokeer, A., Larsson, A.K., and Mannervik, B. 2005. Residue 234 in glutathione transferase T1-1 plays a pivotal role in the catalytic activity and the selectivity against alternative substrates. Biochem. J. 388:387–392.
  • Svensson, K., Olofsson, K., and Osterman-Golkar, S. (1991). Alkylation of DNA and hemoglobin in the mouse following exposure to propene and propylene oxide. Chem. Biol. Interact. 78:55–66.
  • Swenberg, J.A., Afonin, V., Boysen, G., Colvin, D., Gao, L., Nakamura, J., Schoonhoven, R., and Upton, P.B. (2006). DNA adducts, hemoglobin adducts, abasic sites and cell proliferation in rats and mice exposed to propylene oxide by inhalation. Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, NC. May 31.
  • Uhlig, S., and Wendel, A. (1992). The physiological consequences of glutathione variations. Life Sci. 51:1083–1094.
  • U.S. EPA. (1990). Propylene oxide (CASRN 75-56-9). Reference concentration for chronic inhalation exposure (RfC). Last revised 11-01-1990. http://www.epa.gov/iris/subst/0403.htm. Accessed June 26, 2007.
  • U.S. EPA. (2005). Guidelines for carcinogen risk assessment. EPA/630/P-03/001B, March 2005. http://www.epa.gov/osa/raf/publications/pdfs/CANCER_GUIDELINES_FINAL_3-25-05.PDF
  • U.S. EPA/OPPTS. (2006). Re-registration eligibility decision for propylene oxide (CASRN 75-56-9). EPA 738-R-06-029. http://www.epa.gov/pesticides/reregistration/REDs/propylene_oxide_red.pdf. Accessed April 12, 2008.
  • Weiler, E., and Farbman, A. I. (1997). Proliferation in the rat olfactory epithelium: Age-dependent changes. J. Neurosci. 17:3610–3622.
  • Westerveld, G.J., Dekker, I., Voss, H.P., Bast, A., and Scheeren, R.A. (1997). Antioxidant levels in the nasal mucosa of patients with chronic sinusitis and healthy controls. Arch. Otolaryngol. Head Neck Surg. 123: 201–204.
  • Young, J.T., Mattson, J.L., Albee, R.R., and Schuetz, D.J. (1985). Propylene oxide: assessment of neurotoxic potential in male rats. Final report. Dow Chemical U.S.A., Midland, MI.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.